Astronomy Online

Efavirenz, Emtricitabine, and Tenofovir have all been approved by the FDA for the treatment of HIV infection. Efavirenz and Emtricitabine have also be approved for use in children who are infected with HIV.Often these medications are prescribed together, and the drug manufacturers have been all put into one once daily tablet. Atripla (Tenovir/Emtricitabine/Efavirenz) came onto the market in July of 2006 as a FDA approved treatment for HIV. Atripla may be used as a complete regimen or in combination with other HIV medications.

This has made Atripla a leading medication in the battle against HIV and has help simplifiy HIV regimens a great deal. This helps patients dealing with HIV by making their regimens both more simple and regimens more effective. This helps to reduce the amount of drug resistant mutations that occur due to misdoses.

Viraday does not cure or prevent HIV infection or HIV and does not reduce the risk of passing the virus to other people. Along with its desired effects, Atripla can cause some unwanted effects. Serious side effects of efavirenz include abnormal thinking, confusion, depression, hallucinations, memory loss, paranoid thinking, and thoughts of suicide. Patients can develop a severe rash. NRTIs in Atripla can sometimes cause a fatal lactic acidosis and disease of liver as well as blood problems or muscle weakness. Your doctor should be notified if you experience joint pain or muscle pain and trouble breathing, weakness, stomach pain with nausea or vomiting, feeling cold, dizziness, irregular heartbeat, jaundice, dark urine or loss of appetite. Patients should tell their doctor if they experience any of these side effects. Often side effects that are not as serious generally lessen with continued use of Atripla. Individuals should tell a doctor if these side effects continue or are bothersome. Stopping Atripla can cause a adverse reaction if you are infected with hepatitis B.